Undisclosed allogenic CD7 CAR-T
/ Microcrispr Pvt Ltd
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
Design and Development of a Fratricide-Resistant Allogenic CD7 CAR-T Cell Therapy with an RQR8 Safety Switch for the Treatment of T-Cell Acute Lymphoblastic Leukemia
(SITC 2026)
- No abstract available
CAR T-Cell Therapy • Clinical • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • T Acute Lymphoblastic Leukemia • T-cell Acute Lymphoblastic Lymphoma • CD7
1 to 1
Of
1
Go to page
1